12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
The article highlights significant intraday movements in health care stocks on Friday. Notable gainers include Novo Integrated Sciences (NVOS), Anebulo Pharmaceuticals (ANEB), Annovis Bio (ANVS), Vaccinex (VCNX), Genprex (GNPX), and Purple Biotech (PPBT). Significant losers include Calidi Biotherapeutics (CLDI), Summit Therapeutics (SMMT), Heart Test Laboratories (HSCS), Humacyte (HUMA), Concord Medical Services (CCM), and Pulse Biosciences (PLSE).
May 31, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Concord Medical Services (CCM) stock decreased by 17.12% to $0.5, with a market cap of $21.7 million.
The significant price decline indicates negative sentiment or news, likely leading to short-term losses.
CONFIDENCE 70
IMPORTANCE 55
RELEVANCE 100
NEGATIVE IMPACT
Calidi Biotherapeutics (CLDI) stock declined by 31.0% to $0.21, with a market cap of $10.5 million.
The significant price decline indicates negative sentiment or news, likely leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Heart Test Laboratories (HSCS) shares fell 17.63% to $5.61, with a market cap of $3.6 million.
The significant price decline indicates negative sentiment or news, likely leading to short-term losses.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Humacyte (HUMA) shares fell 17.48% to $7.51, with a market cap of $894.2 million.
The notable price decline suggests negative developments or investor sentiment, likely leading to short-term losses.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Pulse Biosciences (PLSE) shares declined by 16.1% to $10.11, with a market cap of $558.3 million.
The notable price decline suggests negative developments or investor sentiment, likely leading to short-term losses.
CONFIDENCE 65
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Summit Therapeutics (SMMT) shares decreased by 19.13% to $8.83, with a market cap of $6.1 billion.
The notable price decline suggests negative developments or investor sentiment, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Anebulo Pharmaceuticals (ANEB) shares increased by 33.33% to $2.8, with a market cap of $72.6 million.
The substantial price increase suggests positive developments or investor sentiment, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Annovis Bio (ANVS) stock increased by 21.33% to $7.28, with a market cap of $81.3 million.
The notable price increase indicates positive sentiment or news, likely leading to short-term gains.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Genprex (GNPX) stock moved upwards by 19.42% to $2.89, with a market cap of $6.0 million.
The notable price increase indicates positive sentiment or news, likely leading to short-term gains.
CONFIDENCE 70
IMPORTANCE 55
RELEVANCE 100
POSITIVE IMPACT
Novo Integrated Sciences (NVOS) shares rose 120.0% to $0.99, with a market cap of $18.9 million.
The significant price increase indicates strong positive sentiment or news, likely leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Purple Biotech (PPBT) shares moved upwards by 19.35% to $1.02, with a market cap of $26.6 million.
The significant price increase suggests positive developments or investor sentiment, likely leading to short-term gains.
CONFIDENCE 65
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
Vaccinex (VCNX) stock increased by 20.96% to $6.29, with a market cap of $9.9 million.
The significant price increase suggests positive developments or investor sentiment, likely leading to short-term gains.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100